These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31965286)

  • 1. The relationship between glucose homeostasis status and prostate size in aging Chinese males with benign prostatic hyperplasia.
    Wu Y; Ding Y; Cao QF; Qian SB; Wang C; Duan HQ; Gu J; Shen HB
    World J Urol; 2020 Nov; 38(11):2923-2931. PubMed ID: 31965286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels.
    Kim WT; Yun SJ; Choi YD; Kim GY; Moon SK; Choi YH; Kim IY; Kim WJ
    J Korean Med Sci; 2011 Sep; 26(9):1214-8. PubMed ID: 21949470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of prostatic morphological parameters and clinical progression in aging Chinese men with benign prostatic hyperplasia: Results from a cross-sectional study.
    Qian S; Zhang S; Xia W; Xu D; Qi J; Shen H; Wu Y
    Prostate; 2021 Jun; 81(8):478-486. PubMed ID: 33860949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking pre-diabetes with benign prostate hyperplasia. IGFBP-3: a conductor of benign prostate hyperplasia development orchestra?
    Protopsaltis I; Ploumidis A; Sergentanis TN; Constantoulakis P; Tzirogiannis K; Kyprianidou C; Papazafiropoulou AK; Melidonis A; Delakas D
    PLoS One; 2013; 8(12):e81411. PubMed ID: 24367483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.
    Ozden C; Ozdal OL; Urgancioglu G; Koyuncu H; Gokkaya S; Memis A
    Eur Urol; 2007 Jan; 51(1):199-203; discussion 204-6. PubMed ID: 16806666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between prostatic parameters of transrectal ultrasonography and age in patients with benign prostatic hyperplasia].
    Cao NL; Lu QJ; Wang XH; Ni JS; Gu BJ; Hu B
    Zhonghua Nan Ke Xue; 2017 Apr; 23(4):315-318. PubMed ID: 29714415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic factors associated with benign prostatic hyperplasia.
    Parsons JK; Carter HB; Partin AW; Windham BG; Metter EJ; Ferrucci L; Landis P; Platz EA
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2562-8. PubMed ID: 16608892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.
    Hammarsten J; Högstedt B
    Eur Urol; 2001 Feb; 39(2):151-8. PubMed ID: 11223674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(17):1-121. PubMed ID: 23074487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transurethral diode laser enucleation versus transurethral electrovaporization resection of the prostate for benign prostatic hyperplasia with different prostate volumes].
    Liu D; Fan L; Liu C; Liu XJ; Zhu DS; Mu JG; Yao DW; Song Q
    Zhonghua Nan Ke Xue; 2017 Mar; 23(3):217-222. PubMed ID: 29706041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Effectiveness and Safety of Transvesical Open Prostatectomy versus Transurethral Resection of the Prostate in Patients with Benign Prostatic Hyperplasia with a Prostate Weight of 65-40 Gram.
    Sofimajidpour H; Khoshyar A; Zareie B; Sofimajidpour H; Rasouli MA
    Urol J; 2020 Nov; 18(3):289-294. PubMed ID: 33159313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative and total volume of histological components in benign prostatic hyperplasia: relationships between histological components and clinical findings.
    Ishigooka M; Hayami S; Hashimoto T; Suzuki Y; Katoh T; Nakada T
    Prostate; 1996 Aug; 29(2):77-82. PubMed ID: 8700803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety Evaluation of Transurethral Resection of the Prostate versus Plasmakinetic Enucleation of the Prostate in the Treatment of Massive Benign Prostatic Hyperplasia.
    Zhang J; Wang Y; Li S; Jin S; Zhang S; Zhao C; Yang W; Cui S; Liu Y
    Urol Int; 2021; 105(9-10):735-742. PubMed ID: 33524981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia.
    Recker F; Kwiatkowski MK; Pettersson K; Piironen T; Lümmen G; Huber A; Tscholl R
    Eur Urol; 1998; 33(6):549-55. PubMed ID: 9743696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation between clinical outcome and residual prostatic weight ratio after transurethral resection of the prostate for benign prostatic hyperplasia.
    Chen SS; Hong JG; Hsiao YJ; Chang LS
    BJU Int; 2000 Jan; 85(1):79-82. PubMed ID: 10619951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.
    Berger AP; Deibl M; Halpern EJ; Lechleitner M; Bektic J; Horninger W; Fritsche G; Steiner H; Pelzer A; Bartsch G; Frauscher F
    Diabetologia; 2005 Apr; 48(4):784-9. PubMed ID: 15756540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliott SP; Macdonald R; Langsjoen J; Tacklind J; Wilt TJ
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004135. PubMed ID: 22972068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Characteristics of the Transitional Zone in Prostate Growth With Age.
    Cao N; Lu Q; Si J; Wang X; Ni J; Chen L; Gu B; Hu B
    Urology; 2017 Jul; 105():136-140. PubMed ID: 28389262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.